IMC Chicago’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Sell
146,000
-45,400
-24% -$543K ﹤0.01% 3048
2026
Q1
$1.15M Buy
191,400
+2,100
+1% +$15.8K ﹤0.01% 3139
2025
Q4
$1.36M Buy
189,300
+93,800
+98% +$741K ﹤0.01% 2742
2025
Q3
$1.02M Buy
95,500
+29,000
+44% +$285K ﹤0.01% 2697
2025
Q2
$644K Sell
66,500
-18,500
-22% -$191K ﹤0.01% 2737
2025
Q1
$1.27M Sell
85,000
-46,700
-35% -$718K ﹤0.01% 2120
2024
Q4
$1.96M Buy
131,700
+94,600
+255% +$1.54M ﹤0.01% 1887
2024
Q3
$710K Buy
37,100
+6,700
+22% +$139K ﹤0.01% 2230
2024
Q2
$629K Sell
30,400
-100
-0.3% -$1.99K ﹤0.01% 2200
2024
Q1
$573K Buy
+30,500
New +$523K ﹤0.01% 1983

Other funds holding OGN

IMC Chicago's OGN Position: Q2 2026 in Review

IMC Chicago sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 47,531 shares — an estimated $568K sold.

IMC Chicago first reported a position in OGN in Q1 2024 and held it in 4 quarters. The position peaked at $1.3M in Q4 2024. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • IMC Chicago reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 47,531 Organon & Co shares in Q2 2026, an estimated $568K.
  • IMC Chicago first reported a position in Organon & Co in Q1 2024 and held it in 4 quarters.
  • IMC Chicago's Organon & Co position peaked at $1.3M in Q4 2024.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.